Cecile Chenivesse
Overview
Explore the profile of Cecile Chenivesse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
798
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Margelidon-Cozzolino V, Balsamelli J, Carrard J, Ait Yahia S, Gevaert M, Demoulin-Alexikova S, et al.
Inflamm Res
. 2025 Mar;
74(1):52.
PMID: 40082266
Objective And Design: Airway remodelling (AR) is a disabling phenomenon in patients with severe asthma, yet suitable models are lacking. We previously developed a dog allergen-induced murine asthma model characterized...
2.
Hennion N, Bedart C, Vandomber L, Gottrand F, Humez S, Chenivesse C, et al.
Cell Mol Life Sci
. 2025 Mar;
82(1):115.
PMID: 40074941
Some interstitial lung diseases involve pulmonary fibrosis, which is a process that is characterized by the excessive and abnormal accumulation of extracellular matrix in the pulmonary interalveolar space. Although the...
3.
Gephine S, Terce G, Brulois G, Chenivesse C, Le Rouzic O, Grosbois J
Arch Bronconeumol
. 2025 Feb;
PMID: 39893080
No abstract available.
4.
Gephine S, Le Rouzic O, Peres S, Chenivesse C, Grosbois J
BMJ Open
. 2025 Jan;
15(1):e092096.
PMID: 39773805
Objectives: To evaluate the short-term and long-term benefits of adding a weekly educational session to a traditional 8-week home-based pulmonary rehabilitation (PR) programme in people with chronic obstructive pulmonary disease...
5.
Esnault S, Bernau K, Floerke H, Dendooven A, Delaunay E, Dill-McFarland K, et al.
Allergy
. 2024 Dec;
PMID: 39707874
No abstract available.
6.
Ferreira M, Bejan-Angoulvant T, Marchand-Adam S, Mousset E, Mureau E, Jouneau S, et al.
Respir Med Res
. 2024 Dec;
87:101144.
PMID: 39693827
Introduction: Progressive interstitial lung diseases (ILDs) are rare but severe diseases, with high mortality and morbidity, with no effective pharmacological treatment allowing for long-term remission, and therefore no clear therapeutic...
7.
Guirriec Y, Luque-Paz D, Bernard G, Mabo A, Kerjouan M, Menard C, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39624377
Background: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease that may progress towards pulmonary fibrosis. Data about fibrosis prevalence and risk factors are lacking. Methods: In this retrospective multicentre...
8.
Margoline E, Cailliau E, Gephine S, Fry S, Le Rouzic O, Grosbois J, et al.
Clin Exp Allergy
. 2024 Aug;
54(12):1016-1019.
PMID: 39165129
No abstract available.
9.
Valery S, Simon-Tillaux N, Devouassoux G, Bonniaud P, Beurnier A, Boudjemaa A, et al.
J Allergy Clin Immunol
. 2024 Jun;
154(4):922-932.
PMID: 38848878
Background: Switching biologics is now common practice in severe eosinophilic asthma. After insufficient response to anti-IL-5 or 5 receptor (anti-IL-5/5R), the optimal switch between an anti-IL-4R mAb (interclass) or another...
10.
Perotin J, Gauquelin L, Just N, Devouassoux G, Chenivesse C, Bourdin A, et al.
ERJ Open Res
. 2024 Apr;
10(2).
PMID: 38651091
Background: The French RAMSES study is an observational prospective multicentre real-life cohort including severe asthmatic subjects. The objective of the study was to compare the characteristics of patients, in terms...